display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
metastatic/advanced - colorectal cancer (mCRC)endometrial cancer - (neo)adjuvant (NA)
endometrial cancerendometrial cancer - (neo)adjuvant (NA)
pembrolizumab based treatment
pembrolizumab plus lenvatinib LEAP-001/ENGOT-en9 KEYNOTE-775
pembrolizumab plus SoC NRG-GY018_pMMR NRG-GY018_dMMR KEYNOTE-B21

Study type: